Program & Schedule - Thursday, Nov. 8, 2007

This meeting will provide an overview of the use of both primary cells and stem cells in high-throughput screening and the drug-discovery process.  Presentation topics will include: primary cells in drug discovery; primary cells as a tool for ADMET; stem cells & target validation; and emerging applications of stem cells.

< Wednesday, November 7 Thursday, November 8, 2007
7:00am – 2:30pm	Registration
7:00am – 8:00am	Continental Breakfast, Visit Exhibits, Poster Viewing in Exhibit Hall
8:00am – 8:15am	Welcome Remarks Sitta Sittampalam, The Unversity of Kansas Medical Center, USA
8:15am – 9:00am	Plenary Stem Cells: Applications & Opportunities in Modern Drug Discovery detail^ John McNeish, Pfizer, USA
Session 1: Stem Cells & Target Validation Session Chair: Sitta Sittampalam
9:00am – 9:45am	Applications of Stem Cells to Target Validation in Drug Development detail^ Dan Marshak, PerkinElmer, USA
9:45am – 10:30am	Rewiring GPCR Signaling in Stem Cells and Mice; Dissection, Design and Construction Download Presentation Edward C. Hsiao, Gladstone Institutes, UCSF, USA
10:30am – 11:00am	Networking Refreshment Break, Visit Exhibit, Poster Viewing in Exhibit Hall
Session 2: Emerging Applications of Stem Cells Session Chair: Sitta Sittampalam
11:00am – 11:45am	Human Embryonic Stem Cells - Applications for Drug Discovery and Medical Treatment detail^ Veit Bergendahl, University of Wisconsin, USA
11:45am – 12:30pm	Embryonic Stem Cell Technologies: Applications in Drug Discovery & Development detail^ Ralph Snodgrass, VistaGen Therapeutics, Inc.
12:30pm – 1:15pm	Vendor Tutorial Program II
1:15pm – 2:15pm Lunch Break, Visit Exhibits, Poster Viewing in Exhibit Hall
2:15pm – 3:00pm	Functional Tissue Engineering for Musculoskeletal Tissue Repair Using Autogenous Mesenchymal Stem Cells detail^ David Butler, University of Cincinnati, USA
3:00pm – 3:45pm	Primary Human Cell Systems for Drug Discovery: No More Black Box detail^ Ellen L. Berg, BioSeek, Inc., USA
3:45pm - 4:30pm	Incorporating Tissue Architecture and Gradients into Cellular Assays Using Existing HTS Infrastructure detail^ Steven Hayes, Bellbrook Labs
4:30pm - 5:00pm	Question and Answer Session Session Chair: Terry Riss
5:00pm – 5:15pm	Closing Remarks Sitta Sittampalam, Maria Webb, Pharmacopeia, USA